We are delighted to welcome Chugai Pharma Europe as a new member of our Flying Health ecosystem.
- Chugai Pharma Europe (CPE) is a regional business and wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd. (Chugai), one of Japan’s leading research-based pharmaceutical companies, which has been a member of the Roche Group since 2002. Established in 1993 and headquartered in London, CPE delivers health solutions in its core areas of oncology, rheumatology, and haematology, as the regional coordinator of Chugai’s commercial, medical and business activities in Europe.
- The team at CPE believes in the “Power of Together” and that they can achieve more when they work in partnership, collaborate smartly, and share knowledge and experience. CPE offers its partners a wide range of expertise, from researching new molecules to overcoming market access challenges.
- In the spirit of the “Power of Together”, Chugai Pharma Germany, a part of CPE, entered into a multi-year partnership with GAIA, a global pioneer in the research and development of digital therapeutics (DTx), earlier this year. Together, the two companies aim to advance the commercialization of GAIA’s latest digital therapy for patients with rheumatoid arthritis (RA) in Germany.
We share the idea of the “Power of Together” at Flying Health and are therefore very much looking forward to generating new insights and contacts in the field of innovative technologies and digital applications together with Chugai Pharma Europe – on a national and international level.
Please do not hesitate to contact the Flying Health team for any questions or further information.